These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10476546)

  • 1. The molecular perspective: methotrexate.
    Goodsell DS
    Oncologist; 1999; 4(4):340-1. PubMed ID: 10476546
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular perspective: methotrexate.
    Goodsell DS
    Stem Cells; 1999; 17(5):314-5. PubMed ID: 10527466
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methotrexate].
    Schröder F; Schroeder JO
    Dtsch Med Wochenschr; 2000 Nov; 125(47):1435-6. PubMed ID: 11130122
    [No Abstract]   [Full Text] [Related]  

  • 4. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
    Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
    Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical mechanisms of resistance to antimetabolites.
    Harrap KR; Jackson RC
    Antibiot Chemother (1971); 1978; 23():228-37. PubMed ID: 348081
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate.
    Held-Warmkessel J
    Clin J Oncol Nurs; 2000; 4(4):187-8. PubMed ID: 11261104
    [No Abstract]   [Full Text] [Related]  

  • 7. Folate, antifolates, and folate analogs in pediatric oncology.
    Hum MC; Kamen BA
    Invest New Drugs; 1996; 14(1):101-11. PubMed ID: 8880397
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA synthesis as a therapeutic target: the first 65 years.
    Mathews CK
    FASEB J; 2012 Jun; 26(6):2231-7. PubMed ID: 22653564
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there life after methotrexate?
    Bertino JR
    Cancer Invest; 2002; 20(4):593-4. PubMed ID: 12094553
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resistance mechanisms to Methotrexate].
    Jin M; Wu MY
    Zhonghua Er Ke Za Zhi; 2003 May; 41(5):388-90. PubMed ID: 14751076
    [No Abstract]   [Full Text] [Related]  

  • 12. High-mannose-type glycan modifications of dihydrofolate reductase using glycan-methotrexate conjugates.
    Totani K; Matsuo I; Ihara Y; Ito Y
    Bioorg Med Chem; 2006 Aug; 14(15):5220-9. PubMed ID: 16647263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methotrexate--mechanism of action and application].
    Dabkowska B; Dabkowski J
    Pol Merkur Lekarski; 2001 Nov; 11(65):452-5. PubMed ID: 11852822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual case of sarcoidosis in an adult patient with sickle cell disease: management with methotrexate and low dose of steroid.
    Delmonte L; Zamo A; Cantini M; de Franceschi L
    Am J Hematol; 2013 Mar; 88(3):243. PubMed ID: 23335434
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
    Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
    Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methotrexate is lethal to rats. Why give it to children?
    Cole PD; Kamen BA
    Pediatr Hematol Oncol; 2000 Dec; 17(8):609-13. PubMed ID: 11127392
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in individual prediction of methotrexate toxicity: a review.
    Schmiegelow K
    Br J Haematol; 2009 Sep; 146(5):489-503. PubMed ID: 19538530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.